Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study

Bone Marrow Transplant. 2024 Jan;59(1):121-124. doi: 10.1038/s41409-023-02096-z. Epub 2023 Oct 6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Bone Marrow
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Transplants*